Stressgen Licenses Heat Shock Fusion Protein to Roche
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 26 (Table of Contents)
Published: 2 Jul-2002
DOI: 10.3833/pdr.v2002.i26.1031 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Stressgen Biotechnologies signed a deal with Roche to co-develop and commercialize Stressgen’s proprietary product candidate, HspE7...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS